A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema

OBJECTIVE: To compare the safety and efficacy of different doses of intravitreal triamcinolone (ivTA) in treating clinically significant diabetic macular oedema (CSMO). METHODS: 63 eyes of 63 patients with CSMO and central foveal thickness (CFT) of ⩾250 μm on optical coherence tomography were random...

Full description

Saved in:
Bibliographic Details
Main Authors: Lam, Dennis S C, Chan, Carmen K M, Mohamed, Shaheeda, Lai, Timothy Y Y, Li, Kenneth K W, Li, Patrick S H, Tsang, Chi‐Wai, Chan, Wai‐Man, Shanmugam, Mahesh P
Format: Artigo
Language:Inglês
Published: BMJ Group 2007
Subjects:
Clinical Science - Extended Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857621/
https://ncbi.nlm.nih.gov/pubmed/16973659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.102848
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items